在急性骨髓性白血病中进行全源性造血细胞移植
Gray Magee1, Brittany Knick Ragon1
1Department of Hematologic Oncology and Blood Disorders, The Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Best practice & research. Clinical haematology
|June 23, 2023
概括
全基性造血细胞移植 (HCT) 为精选的急性髓性白血病 (AML) 患者提供了治疗方法. 目前正在进行的研究旨在克服移植障碍,如复发,并改善更多AML患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 全基性造血细胞移植 (HCT) 是急性髓性白血病 (AML) 的治愈选择.
- 它通过化疗-放射疗法恢复和移植对抗白血病免疫效应发挥作用.
- 改善条件,供体匹配和支持性护理的改善改善了HCT的结果.
研究的目的:
- 审查 AML 的异构 HCT 的进展和持续挑战.
- 确定未来研究和治疗开发的关键领域.
- 突出在AML治疗中克服移植相关障碍的战略.
主要方法:
- 目前关于AML全源HCT的文献综述.
- 分析影响移植资格和结果的因素.
- 讨论新兴的治疗策略和未来的研究方向.
主要成果:
- HCT改善了AML治疗结果,但挑战仍然存在.
- 复发仍然是治疗失败的主要原因.
- 接受者的健康状况,捐赠者的可用性和获得护理的机会是重大障碍.
结论:
- 尽管取得了进展,但仍有重大障碍阻碍了HCT在AML中的广泛成功.
- 移植后的维护和新型细胞疗法显示出有前途.
- 进一步调查至关重要,以克服剩余的挑战,并改善AML患者的生存率.
相关概念视频
Bone Marrow Sampling and Transplants
363
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K


